Previous Episode: The Lancet: June 18, 2010

Professor Cliff Bailey discusses the potential role of dapagliflozin for the treatment of type 2 diabetes.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv